Neoadjuvant Immune Checkpoint Inhibitor plus Chemotherapy for Resectable Non-small Cell Lung Cancer in Real World

被引：0
|
作者：
Chen, C. [1 ]
机构：
[1] Zunyi Med Univ, Affiliated Hosp, Zunyi, Guizhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Non-small cell lung cancer; Neoadjuvant therapy; PD-1; inhibitor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-24
引用
收藏
页码：S579 / S580
页数：2
相关论文
共 50 条
  • [21] Phase II study of Neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small cell lung cancer
    Ramnath, N
    Sommers, E
    Robinson, L
    Nwogu, C
    Sharma, A
    Cantor, A
    Bepler, G
    CHEST, 2005, 128 (05) : 3467 - 3474
  • [22] Immune Checkpoint Inhibitors in Real-World Treatment of Older Adults with Non-Small Cell Lung Cancer
    Muchnik, Eugene
    Loh, Kah Poh
    Strawderman, Myla
    Magnuson, Allison
    Mohile, Supriya G.
    Estrah, Vered
    Maggiore, Ronald J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 (05) : 905 - 912
  • [23] Tumor microenvironment features decipher the outperformance of neoadjuvant immunochemotherapy over chemotherapy in resectable non-small cell lung cancer
    Cai, Wenhan
    Jing, Miao
    Gu, Yajun
    Bei, Ting
    Zhao, Xiaochen
    Chen, Shiqing
    Wen, Jiaxin
    Gao, Jie
    Wu, Chongchong
    Xue, Zhiqiang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers
    Wu, Xinyu
    Chau, Yi Fung
    Bai, Hua
    Zhuang, Xiaofei
    Wang, Jie
    Duan, Jianchun
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [25] Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer
    Hu, Yan
    Ren, Si-Ying
    Wang, Ruo-Yao
    Zeng, Chao
    Li, Ji-Na
    Xiao, Peng
    Wu, Fang
    Yu, Feng-Lei
    Liu, Wen-Liang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01) : 81 - 88
  • [27] Neoadjuvant Chemoimmunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable Non-small Cell Lung Cancer
    Tianxiang Chen
    Zhengqi Cao
    Yingjia Sun
    Jia Huang
    Shengping Shen
    Yueping Jin
    Long Jiang
    Fengcai Wen
    Xiaochen Zhao
    Ding Zhang
    Yanan Chen
    Mengli Huang
    Hao Chen
    Shun Lu
    Ziming Li
    Annals of Surgical Oncology, 2023, 30 : 7549 - 7560
  • [28] Neoadjuvant Chemoimmunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable Non-small Cell Lung Cancer
    Chen, Tianxiang
    Cao, Zhengqi
    Sun, Yingjia
    Huang, Jia
    Shen, Shengping
    Jin, Yueping
    Jiang, Long
    Wen, Fengcai
    Zhao, Xiaochen
    Zhang, Ding
    Chen, Yanan
    Huang, Mengli
    Chen, Hao
    Lu, Shun
    Li, Ziming
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7549 - 7560
  • [29] Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice
    Huang, Xiaojie
    Pang, Guanchao
    Mao, Zhirong
    Li, Baizhou
    Teng, Zhihua
    Yang, Yan
    Qiu, Zijian
    Chen, Xiuxiu
    Wang, Pingli
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (05)
  • [30] The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Jiang, Long
    Huang, Jia
    Jiang, Shanshan
    Rong, Wenwen
    Shen, Yaofeng
    Li, Chongwu
    Tian, Yu
    Ning, Junwei
    Chen, Xiaoke
    Yang, Yunhai
    Ding, Zhengping
    Li, Ziming
    Luo, Qingquan
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (08) : 2313 - 2321
12345